Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030
For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders is critical in the surveillance of these infectious diseases, boosting market growth in this field.
Inadequate reimbursements are a key problem impeding industry expansion. Medical testing has suffered a 40% decrease in reimbursement over the previous 40 years, according to MedPAC (Medicare Payment Advisory Commission). This reduction, as well as extra economic concerns among healthcare organisations, are significant impediments to the use of innovative diagnostic procedures in clinical laboratories.
Inadequate reimbursements are a key problem impeding industry expansion. Medical testing has suffered a 40% decrease in reimbursement over the previous 40 years, according to MedPAC (Medicare Payment Advisory Commission). This reduction, as well as extra economic concerns among healthcare organisations, are significant impediments to the use of innovative diagnostic procedures in clinical laboratories.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. PRODUCT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Assays & Reagents
5.3. Instruments
5.4. Software
6. DISEASE TYPE: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Hepatitis
6.3. Human Immunodeficiency Virus
6.4. Influenza
6.5. Others
7. TECHNOLOGY: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Immunodiagnostics
7.3. Clinical Microbiology
7.4. Polymerase Chain Reaction
7.5. Next Generation Sequencing
7.6. Others
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. AMGEN, INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. ASTRAZENECA, PLC
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. BAYER AG
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. BRISTOL-MYERS SQUIBB COMPANY
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. ELI LILY AND COMPANY
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.)
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. PFIZER, INC.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC)
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. MERCK KGAA
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. NOVARTIS AG
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
TABLE 1. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 2. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR ASSAYS & REAGENTS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR INSTRUMENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 6. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR HEPATITIS, 2021-2030 (USD BILLION)
TABLE 7. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR HUMAN IMMUNODEFICIENCY VIRUS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR INFLUENZA, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 11. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR IMMUNODIAGNOSTICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 12. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR CLINICAL MICROBIOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR NEXT GENERATION SEQUENCING, 2021-2030 (USD BILLION)
TABLE 15. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 16. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 17. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 18. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 19. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 20. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 21. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 22. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 23. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 24. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 25. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 26. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 27. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 28. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 29. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 30. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 31. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 32. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 33. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 34. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 35. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 36. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 37. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 38. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 39. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 40. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 41. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 42. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 43. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 44. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 45. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 46. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 47. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 48. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 49. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 50. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 51. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 52. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 53. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 54. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 55. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 56. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 57. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 58. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 59. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 60. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 61. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 62. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 63. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 64. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 65. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 66. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 67. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 68. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 69. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 70. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 71. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 72. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 73. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 74. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 75. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 76. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 77. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 78. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 79. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 80. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 81. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 82. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 83. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 84. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 85. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 86. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 87. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 88. AMGEN, INC. : FINANCIALS
TABLE 89. AMGEN, INC. : PRODUCTS & SERVICES
TABLE 90. AMGEN, INC. : RECENT DEVELOPMENTS
TABLE 91. ASTRAZENECA, PLC: FINANCIALS
TABLE 92. ASTRAZENECA, PLC: PRODUCTS & SERVICES
TABLE 93. ASTRAZENECA, PLC: RECENT DEVELOPMENTS
TABLE 94. BAYER AG: FINANCIALS
TABLE 95. BAYER AG: PRODUCTS & SERVICES
TABLE 96. BAYER AG: RECENT DEVELOPMENTS
TABLE 97. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS
TABLE 98. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES
TABLE 99. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS
TABLE 100. ELI LILY AND COMPANY: FINANCIALS
TABLE 101. ELI LILY AND COMPANY: PRODUCTS & SERVICES
TABLE 102. ELI LILY AND COMPANY: RECENT DEVELOPMENTS
TABLE 103. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): FINANCIALS
TABLE 104. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): PRODUCTS & SERVICES
TABLE 105. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): RECENT DEVELOPMENTS
TABLE 106. PFIZER, INC. : FINANCIALS
TABLE 107. PFIZER, INC. : PRODUCTS & SERVICES
TABLE 108. PFIZER, INC. : DEVELOPMENTS
TABLE 109. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): FINANCIALS
TABLE 110. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): PRODUCTS & SERVICES
TABLE 111. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): RECENT DEVELOPMENTS
TABLE 112. MERCK KGAA: FINANCIALS
TABLE 113. MERCK KGAA: PRODUCTS & SERVICES
TABLE 114. MERCK KGAA: RECENT DEVELOPMENTS
TABLE 115. NOVARTIS AG: FINANCIALS
TABLE 116. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 117. NOVARTIS AG: RECENT DEVELOPMENTS
CHART. 1. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 2. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 3. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR ASSAYS & REAGENTS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
CHART. 4. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR INSTRUMENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 5. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 6. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 7. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR HEPATITIS, 2021-2030 (USD BILLION)
CHART. 8. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR HUMAN IMMUNODEFICIENCY VIRUS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 9. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR INFLUENZA, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 10. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 11. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 12. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR IMMUNODIAGNOSTICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 13. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR CLINICAL MICROBIOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 14. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 15. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR NEXT GENERATION SEQUENCING, 2021-2030 (USD BILLION)
CHART. 16. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 17. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 18. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 19. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 20. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 21. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 22. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 23. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 24. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 25. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 26. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 27. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 28. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 29. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 30. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 31. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 32. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 33. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 34. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 35. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 36. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 37. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 38. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 39. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 40. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 41. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 42. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 43. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 44. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 45. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 46. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 47. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 48. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 49. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 50. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 51. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 52. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 53. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 54. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 55. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 56. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 57. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 58. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 59. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 60. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 61. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 62. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 63. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 64. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 65. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 66. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 67. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 68. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 69. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 70. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 71. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 72. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 73. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 74. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 75. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 76. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 77. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 78. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 79. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 80. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 81. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 82. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 83. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 84. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 85. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 86. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 87. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 88. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 89. AMGEN, INC. : FINANCIALS
CHART. 90. AMGEN, INC. : PRODUCTS & SERVICES
CHART. 91. AMGEN, INC. : RECENT DEVELOPMENTS
CHART. 92. ASTRAZENECA, PLC: FINANCIALS
CHART. 93. ASTRAZENECA, PLC: PRODUCTS & SERVICES
CHART. 94. ASTRAZENECA, PLC: RECENT DEVELOPMENTS
CHART. 95. BAYER AG: FINANCIALS
CHART. 96. BAYER AG: PRODUCTS & SERVICES
CHART. 97. BAYER AG: RECENT DEVELOPMENTS
CHART. 98. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS
CHART. 99. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES
CHART. 100. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS
CHART. 101. ELI LILY AND COMPANY: FINANCIALS
CHART. 102. ELI LILY AND COMPANY: PRODUCTS & SERVICES
CHART. 103. ELI LILY AND COMPANY: RECENT DEVELOPMENTS
CHART. 104. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): FINANCIALS
CHART. 105. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): PRODUCTS & SERVICES
CHART. 106. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): RECENT DEVELOPMENTS
CHART. 107. PFIZER, INC. : FINANCIALS
CHART. 108. PFIZER, INC. : PRODUCTS & SERVICES
CHART. 109. PFIZER, INC. : DEVELOPMENTS
CHART. 110. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): FINANCIALS
CHART. 111. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): PRODUCTS & SERVICES
CHART. 112. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): RECENT DEVELOPMENTS
CHART. 113. MERCK KGAA: FINANCIALS
CHART. 114. MERCK KGAA: PRODUCTS & SERVICES
CHART. 115. MERCK KGAA: RECENT DEVELOPMENTS
CHART. 116. NOVARTIS AG: FINANCIALS
CHART. 117. NOVARTIS AG: PRODUCTS & SERVICES
CHART. 118. NOVARTIS AG: RECENT DEVELOPMENTS
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. PRODUCT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Assays & Reagents
5.3. Instruments
5.4. Software
6. DISEASE TYPE: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Hepatitis
6.3. Human Immunodeficiency Virus
6.4. Influenza
6.5. Others
7. TECHNOLOGY: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Immunodiagnostics
7.3. Clinical Microbiology
7.4. Polymerase Chain Reaction
7.5. Next Generation Sequencing
7.6. Others
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. AMGEN, INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. ASTRAZENECA, PLC
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. BAYER AG
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. BRISTOL-MYERS SQUIBB COMPANY
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. ELI LILY AND COMPANY
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.)
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. PFIZER, INC.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC)
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. MERCK KGAA
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. NOVARTIS AG
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
TABLE 1. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 2. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR ASSAYS & REAGENTS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR INSTRUMENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 6. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR HEPATITIS, 2021-2030 (USD BILLION)
TABLE 7. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR HUMAN IMMUNODEFICIENCY VIRUS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR INFLUENZA, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 11. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR IMMUNODIAGNOSTICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 12. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR CLINICAL MICROBIOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR NEXT GENERATION SEQUENCING, 2021-2030 (USD BILLION)
TABLE 15. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 16. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 17. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 18. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 19. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 20. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 21. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 22. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 23. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 24. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 25. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 26. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 27. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 28. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 29. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 30. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 31. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 32. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 33. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 34. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 35. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 36. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 37. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 38. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 39. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 40. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 41. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 42. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 43. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 44. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 45. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 46. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 47. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 48. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 49. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 50. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 51. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 52. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 53. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 54. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 55. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 56. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 57. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 58. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 59. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 60. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 61. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 62. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 63. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 64. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 65. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 66. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 67. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 68. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 69. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 70. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 71. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 72. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 73. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 74. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 75. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 76. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 77. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 78. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 79. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 80. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 81. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 82. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 83. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 84. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 85. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 86. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
TABLE 87. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 88. AMGEN, INC. : FINANCIALS
TABLE 89. AMGEN, INC. : PRODUCTS & SERVICES
TABLE 90. AMGEN, INC. : RECENT DEVELOPMENTS
TABLE 91. ASTRAZENECA, PLC: FINANCIALS
TABLE 92. ASTRAZENECA, PLC: PRODUCTS & SERVICES
TABLE 93. ASTRAZENECA, PLC: RECENT DEVELOPMENTS
TABLE 94. BAYER AG: FINANCIALS
TABLE 95. BAYER AG: PRODUCTS & SERVICES
TABLE 96. BAYER AG: RECENT DEVELOPMENTS
TABLE 97. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS
TABLE 98. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES
TABLE 99. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS
TABLE 100. ELI LILY AND COMPANY: FINANCIALS
TABLE 101. ELI LILY AND COMPANY: PRODUCTS & SERVICES
TABLE 102. ELI LILY AND COMPANY: RECENT DEVELOPMENTS
TABLE 103. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): FINANCIALS
TABLE 104. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): PRODUCTS & SERVICES
TABLE 105. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): RECENT DEVELOPMENTS
TABLE 106. PFIZER, INC. : FINANCIALS
TABLE 107. PFIZER, INC. : PRODUCTS & SERVICES
TABLE 108. PFIZER, INC. : DEVELOPMENTS
TABLE 109. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): FINANCIALS
TABLE 110. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): PRODUCTS & SERVICES
TABLE 111. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): RECENT DEVELOPMENTS
TABLE 112. MERCK KGAA: FINANCIALS
TABLE 113. MERCK KGAA: PRODUCTS & SERVICES
TABLE 114. MERCK KGAA: RECENT DEVELOPMENTS
TABLE 115. NOVARTIS AG: FINANCIALS
TABLE 116. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 117. NOVARTIS AG: RECENT DEVELOPMENTS
CHART. 1. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 2. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 3. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR ASSAYS & REAGENTS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
CHART. 4. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR INSTRUMENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 5. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 6. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 7. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR HEPATITIS, 2021-2030 (USD BILLION)
CHART. 8. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR HUMAN IMMUNODEFICIENCY VIRUS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 9. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR INFLUENZA, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 10. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 11. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 12. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR IMMUNODIAGNOSTICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 13. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR CLINICAL MICROBIOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 14. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 15. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR NEXT GENERATION SEQUENCING, 2021-2030 (USD BILLION)
CHART. 16. INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 17. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 18. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 19. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 20. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 21. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 22. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 23. U.S INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 24. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 25. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 26. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 27. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 28. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 29. MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 30. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 31. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 32. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 33. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 34. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 35. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 36. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 37. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 38. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 39. U.K INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 40. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 41. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 42. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 43. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 44. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 45. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 46. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 47. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 48. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 49. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 50. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 51. ROE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 52. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 53. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 54. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 55. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 56. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 57. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 58. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 59. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 60. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 61. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 62. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 63. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 64. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 65. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 66. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 67. REST OF APAC INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 68. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 69. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 70. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 71. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 72. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 73. BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 74. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 75. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 76. ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 77. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 78. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 79. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 80. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 81. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 82. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 83. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 84. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 85. UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 86. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 87. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY DISEASE TYPE, 2021-2030 (USD BILLION)
CHART. 88. REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
CHART. 89. AMGEN, INC. : FINANCIALS
CHART. 90. AMGEN, INC. : PRODUCTS & SERVICES
CHART. 91. AMGEN, INC. : RECENT DEVELOPMENTS
CHART. 92. ASTRAZENECA, PLC: FINANCIALS
CHART. 93. ASTRAZENECA, PLC: PRODUCTS & SERVICES
CHART. 94. ASTRAZENECA, PLC: RECENT DEVELOPMENTS
CHART. 95. BAYER AG: FINANCIALS
CHART. 96. BAYER AG: PRODUCTS & SERVICES
CHART. 97. BAYER AG: RECENT DEVELOPMENTS
CHART. 98. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS
CHART. 99. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES
CHART. 100. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS
CHART. 101. ELI LILY AND COMPANY: FINANCIALS
CHART. 102. ELI LILY AND COMPANY: PRODUCTS & SERVICES
CHART. 103. ELI LILY AND COMPANY: RECENT DEVELOPMENTS
CHART. 104. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): FINANCIALS
CHART. 105. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): PRODUCTS & SERVICES
CHART. 106. F. HOFFMANN-LA ROCHE, LTD. (GENENTECH, INC.): RECENT DEVELOPMENTS
CHART. 107. PFIZER, INC. : FINANCIALS
CHART. 108. PFIZER, INC. : PRODUCTS & SERVICES
CHART. 109. PFIZER, INC. : DEVELOPMENTS
CHART. 110. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): FINANCIALS
CHART. 111. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): PRODUCTS & SERVICES
CHART. 112. JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC): RECENT DEVELOPMENTS
CHART. 113. MERCK KGAA: FINANCIALS
CHART. 114. MERCK KGAA: PRODUCTS & SERVICES
CHART. 115. MERCK KGAA: RECENT DEVELOPMENTS
CHART. 116. NOVARTIS AG: FINANCIALS
CHART. 117. NOVARTIS AG: PRODUCTS & SERVICES
CHART. 118. NOVARTIS AG: RECENT DEVELOPMENTS
